InvestorsHub Logo

cybermich

11/02/20 12:31 AM

#330976 RE: steelyeye #330975

Thanks for the reminder.

I have a feeling a lot of conversations have been going on behind the scenes.

As requested an encore of a poem I wrote just for Infinity:)...

B for Absssi is phase 3 ready
B for Om is as well
B for UP is ready to go
B for UC was dosed in a pill
(and I assume your favorite still)
which brings us to B for C
now what do we know?
not only 3rd party validation
but the help of Dr. DeGrado..
and what do we gleam
from all those other Brilacidin trials?
for the purpose of B for C
there is an established safety profile...
when compared to Remdesivir
which inhibits viral reproduction
B will be better
and has a 3 in 1 antiviral
mechanism of action...
we can mention the high SI
which also supports
B against C in the fight
Now you speak of miracles?
said the lung test had no chance
and yet the Silico Molecular Screening Study
revealed it was not just happenstance...
you can flip that coin
over 11,500 times
or wait for each trial result
for one more sign..
or you can realize
B was developed over thousands of hours
(thats a lot of time:))
using supercomputers
and AI..
the evidence is there
in the science to see..
and no matter what you and I say
its not up to you and me..
Now you speak of miracles?
when this journey is through
we'll look back..
and see the miracle coming true.
(there's already proof of the miracle Infinity:)

p.s. the trial is coming:)

DaubersUP

11/02/20 1:15 AM

#330979 RE: steelyeye #330975

Gilead would be foolish to not open discussion on license agreement for combo. I think the just announced 800 million plus Revs from Remdesivir.

If this combo is accurate as to pre clinical results...this could potentially be a blockbuster combo.

IMO.

Or another BP could see the potential and jump in front to block Gilead from this move to own half of cocktail. That would be smart move.